Cardiovascular. Disease, diseased - cardiovascular
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria:In this trial patients with coronary artery disease more than 70 percent at least in one coronary vessel with Ejection Fraction more than 40 percent in recent Echo cardiograph without acute evidence of ischemia or congestive heart failure symptoms were selected and are divide randomly into two groups. exclusion criteria:patients with acute evidence of ischemia or congestive heart failure symptoms are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: At the beginning and at the end of 8 weeks. Method of measurement: Electrocardiogram.;Blood pressure. Timepoint: At the beginning and at the end of 8 weeks. Method of measurement: Sphygmomanometer. | — |
Primary
| Measure | Time frame |
|---|---|
| Brain Natriuretic Peptide. Timepoint: Before intervention and 2 months after intervention. Method of measurement: ELISA.;C- Reactive Protein. Timepoint: Before intervention and 2 months after intervention. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Science